Skip to main content
. 2021 Oct 12;3(4):212–217. doi: 10.1016/j.smhs.2021.09.003

Fig. 2.

Fig. 2

mRNA abundance of components of the extracellular matrix after 3 and 28 days of recovery following bupivacaine induced acute muscle injury. (A) Fibronectin mRNA abundance 3 days post bupivacaine, (B) Collagen I mRNA abundance 3 days post bupivacaine, (C) Collagen III mRNA abundance 3 days post bupivacaine, (D) Collagen III:I, 3 days post bupivacaine. (E) Fibronectin mRNA abundance 28 days post bupivacaine, (F) Collagen I mRNA abundance 28 days post bupivacaine, (G) Collagen III mRNA abundance 28 days post bupivacaine, (H) Collagen III:I, 28 days post bupivacaine. Significant main effects of injury indicated by # and diet by †. Interaction indicated by Ω.